VeriStar Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lamb Weston
LW
|
+$7.14M |
| 2 |
US Foods
USFD
|
+$5.79M |
| 3 |
Sensata Technologies
ST
|
+$4.53M |
| 4 |
Fortune Brands Innovations
FBIN
|
+$3.46M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$2.79M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$10.6M |
| 2 |
Molina Healthcare
MOH
|
+$1.48M |
| 3 |
Booking.com
BKNG
|
+$624K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.51% |
| 2 | Consumer Staples | 22.17% |
| 3 | Healthcare | 18.83% |
| 4 | Industrials | 15.39% |
| 5 | Consumer Discretionary | 9.86% |
Similar funds
VeriStar Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, VeriStar Capital Management held 12 positions worth $152M, up 29% from $117M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
VeriStar Capital Management deployed $14.3M of net new capital in Q4 2023, opening 1 new position and adding to 6 existing holdings. Its largest new stake was Fiserv Inc: 22,700 shares worth $3.02M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was Molina Healthcare, an estimated $1.48M trimmed.
- VeriStar Capital Management's largest Q4 2023 buy was Fiserv Inc: 22,700 shares worth $3.02M.
- VeriStar Capital Management added most to Lamb Weston in Q4 2023, an estimated $7.14M increase.
- VeriStar Capital Management's biggest Q4 2023 reduction was Molina Healthcare, cutting an estimated $1.48M.
- VeriStar Capital Management fully exited Centene in Q4 2023, selling an estimated $10.6M.
- VeriStar Capital Management's ten largest holdings make up 98% of its $152M portfolio in Q4 2023.
- VeriStar Capital Management opened 1 new position and closed 1 in Q4 2023.
- VeriStar Capital Management's portfolio value rose 29% quarter-over-quarter to $152M.
Based on VeriStar Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.